about
Improving identification of lynch syndrome patients: a comparison of research data with clinical records.The impact of risk-reducing hysterectomy and bilateral salpingo-oophorectomy on survival in patients with a history of breast cancer--a population-based data linkage study.Prognostic significance of tumor angiogenesis in epithelial ovarian cancer.Safety, feasibility and effects of an individualised walking intervention for women undergoing chemotherapy for ovarian cancer: a pilot study.Do breast cancer survivors benefit from prophylactic removal of uterus and ovaries? A population-based data linkage replication study.Lack of impact of platinum dose intensity on the outcome of ovarian cancer patients. 10-year results of a prospective randomised phase III study comparing carboplatin-cisplatin with cyclophosphamide-cisplatin.Potential hospital cost-savings attributed to improvements in outcomes for colorectal cancer surgery following self-auditPretreatment malnutrition and quality of life - association with prolonged length of hospital stay among patients with gynecological cancer: a cohort studyRisk of endometrial cancer for women diagnosed with HNPCC-related colorectal carcinomaEndometrial cancer: accuracy of the finding of a well differentiated tumor at dilatation and curettage compared to the findings at subsequent hysterectomy.Primary fallopian tube carcinoma: the Queensland experience.Knowledge, attitudes and referral patterns of lynch syndrome: a survey of clinicians in australiaTumor mismatch repair immunohistochemistry and DNA MLH1 methylation testing of patients with endometrial cancer diagnosed at age younger than 60 years optimizes triage for population-level germline mismatch repair gene mutation testing.Serum HE4 detects recurrent endometrial cancer in patients undergoing routine clinical surveillance.Feasibility and safety of total laparoscopic radical hysterectomy.The value of serum CA125 for the development of virtual follow-up strategies for patients with epithelial ovarian cancer: a retrospective studyCA 125 regression after two completed cycles of chemotherapy: lack of prediction for long-term survival in patients with advanced ovarian cancer.The cost-effectiveness of total laparoscopic hysterectomy compared to total abdominal hysterectomy for the treatment of early stage endometrial cancer.Laparoscopy in the treatment of ovarian tumours of low malignant potential.Differences in Epidural and Analgesic Use in Patients with Apparent Stage I Endometrial Cancer Treated by Open versus Laparoscopic Surgery: Results from the Randomised LACE TrialMolecular, pathologic, and clinical features of early-onset endometrial cancer: identifying presumptive Lynch syndrome patients.Disease-free survival after vaginal vault brachytherapy versus observation for patients with node-negative intermediate-risk endometrial adenocarcinoma.Metastasis of ovarian cancer is mediated by kallikrein related peptidases.Quality of life of women with lower-limb lymphedema following gynecological cancer.Efficacy of oral or intrauterine device-delivered progestin in patients with complex endometrial hyperplasia with atypia or early endometrial adenocarcinoma: a meta-analysis and systematic review of the literature.Aspirin, nonsteroidal anti-inflammatory drugs, paracetamol and risk of endometrial cancer: a case-control study, systematic review and meta-analysis.Feasibility and outcomes of ureteroureterostomy and extravesical ureteroneocystostomy as part of radical surgery for infiltrating gynecologic disease.Consideration for safe and effective gynaecological laparoscopy in the obese patient.Effect of Total Laparoscopic Hysterectomy vs Total Abdominal Hysterectomy on Disease-Free Survival Among Women With Stage I Endometrial Cancer: A Randomized Clinical Trial.p53 protein overexpression: a strong prognostic factor in uterine papillary serous carcinoma.Lymphedema following gynecological cancer: Results from a prospective, longitudinal cohort study on prevalence, incidence and risk factors.Nutrition interventions in patients with gynecological cancers requiring surgery.The shift toward neo-adjuvant chemotherapy and interval debulking surgery for management of advanced ovarian and related cancers in a population-based setting: Impact on clinical outcomes.Real-world surgical outcomes of a gelatin-hemostatic matrix in women requiring a hysterectomy: a matched case-control study.Advanced cytoreductive surgery: Asia Pacific perspective.Family history of cancer predicts endometrial cancer risk independently of Lynch Syndrome: Implications for genetic counselling.Elderly patients with stage III or IV ovarian cancer: should they receive standard care?Women with self-reported lower-limb lymphedema after treatment for gynecological cancers: are they more likely to self-report psychosocial symptoms and less likely to use services?In vitro cytokine and prostaglandin production by amnion cells in the presence of bacteria.Thrombosis with paclitaxel.
P50
Q30580847-BE945180-B96C-46AD-9B71-59975C07EDA6Q30677729-FB3DDA5D-EA60-44E1-8EA7-08EF971D23F5Q30722541-0FD6D690-B86D-4021-834D-26BDF1786E30Q31030585-BDF9E98C-4941-490B-A4D8-7C2F6FD2E319Q31102791-031605BD-551C-4E00-BB3E-0BFBE31A76A0Q33347916-9885E4D2-93DE-455D-905B-08990FD34C4DQ33526843-B7A32FCD-0ADD-4C00-AD42-F461D1C21EE7Q33585888-12FFEFDF-A7A6-43D4-A565-688490564414Q34163849-A0E1CC5E-E0C5-4EAD-8944-49D4AD4E2630Q34176165-B2ABB2DF-4C3F-47D3-A011-D6933B13EE58Q34206271-80C9E98C-514A-4814-B773-03047B789341Q34683932-8DE1209A-B826-4387-ABD7-6DA68922DB54Q35063442-975C455E-F3DF-4EB1-8EDB-EF5271A6DE78Q35128002-8D120EC8-D6E7-4978-811E-59C4D22800E0Q35563747-85377468-E5BC-4CEE-BB3C-5A676C119DFBQ35916044-CEF0F93A-446F-48D8-AA11-96F373D04ADEQ36619691-DA378DE5-19A2-460B-9CB9-954A68B226E8Q36809978-62A43CFD-A7BC-499E-AF87-23EA61F3714FQ36996534-455E2EDC-0578-463D-8786-70EA72710C8AQ37057854-26FFB00B-AC8C-4228-BCC9-D7B3C13B25DDQ37098318-8C67BF61-5740-47CD-B6C3-CA40F9CD3C0AQ37263055-722F99F6-C473-4FA1-9DC8-9CDB9AA1B9FEQ37480184-9D7E27B5-0654-42E4-84DC-9F7CE03D7FCBQ37889266-093002CE-C07E-4F65-8656-3DCC02BC6AAAQ37971128-459BF545-62A5-4C15-89FA-65C7909516F8Q38025038-C69921BE-1EA7-40DB-9572-7240DB6AD1FAQ38116345-8A56BCAE-F743-4A03-AD9E-7746C8F6E3B4Q38298016-88B38602-05D9-4A97-B9FC-86856CD64B5BQ38378900-E06EC4FA-527A-4430-A87B-CC3989BA371EQ38470642-67FBDEB6-A3F6-4650-990B-16FCAB7CA8C4Q38669922-1735AC32-B913-4A64-B2F5-ED7052972855Q38760256-B4272D5A-8075-4982-BEBD-1919B3A33E18Q39441629-D3BAEEF3-D664-455B-8462-27555D423148Q39751347-9E453669-D47E-49CD-9538-5D6D918A1089Q39963736-003CC9B6-D0EA-4224-8069-25A8F0EFDA95Q40077748-8BB36D04-55AE-4355-B1C7-C2E730C61F31Q40156485-B67370D0-ED5D-4DED-881C-1C6A5160266AQ41083227-7D49018E-32A2-4DDC-8800-82C5B29480D9Q42438921-26CCCC14-1D54-4C2F-9D36-61A7B29CB030Q42563548-82F44976-5C98-45B3-B5D8-7C35AA00A42B
P50
description
onderzoeker
@nl
researcher ORCID ID = 0000-0003-2199-1117
@en
name
Andreas Obermair
@ast
Andreas Obermair
@en
Andreas Obermair
@es
Andreas Obermair
@nl
type
label
Andreas Obermair
@ast
Andreas Obermair
@en
Andreas Obermair
@es
Andreas Obermair
@nl
prefLabel
Andreas Obermair
@ast
Andreas Obermair
@en
Andreas Obermair
@es
Andreas Obermair
@nl
P106
P31
P496
0000-0003-2199-1117